• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心血管生理学对剂量/药代动力学及药代动力学/药效学关系的影响。

The influence of cardiovascular physiology on dose/pharmacokinetic and pharmacokinetic/pharmacodynamic relationships.

作者信息

Fagiolino Pietro, Eiraldi Rosa, Vázquez Marta

机构信息

Pharmacology and Biopharmaceutics, Faculty of Chemistry, University of the Republic of Uruguay, Montevideo, Uruguay.

出版信息

Clin Pharmacokinet. 2006;45(5):433-48. doi: 10.2165/00003088-200645050-00001.

DOI:10.2165/00003088-200645050-00001
PMID:16640451
Abstract

Inter- and intraindividual variability in the relationship between dose and clinical--or pharmacodynamic--response of a drug can be analysed in two steps: firstly, by considering the plasma pharmacokinetic response to a given dose and, secondly, by the connection between both pharmacokinetic and pharmacodynamic responses. As the cardiovascular system is the means of transport of endogenous and exogenous substances, blood flow fraction destined to each organ determines the relative mass of solute in plasma, which is constantly in contact with the tissue. Hence, not only the rate but also the extent of drug transfer would be increased when tissues are irrigated by a higher fraction of cardiac output. Aging and circadian rhythms present similar cardiac output distribution patterns when moving from young to aged adult and from nocturnal to diurnal hours. These two changes lead to an increased blood flow delivery to the extra-splanchnic-renal region in the elderly and in the morning, but with a decreased cardiac output in aged individuals and an increased one during the day. This scenario allows us to forecast substance concentrations outside the blood vessels, which are responsible for the extent of drug elimination and the intensity of drug effect. So available data on disposition and pharmacodynamics of drugs might be explained from another point of view that challenges current knowledge. Furthermore, the administration of cardiovascular active drugs might reverse the chronological sequence between pharmacokinetic and pharmacodynamic responses, since they could modify blood flow distribution.

摘要

药物剂量与临床(或药效学)反应之间的个体间和个体内变异性可通过两个步骤进行分析:首先,考虑对给定剂量的血浆药代动力学反应;其次,考虑药代动力学和药效学反应之间的联系。由于心血管系统是内源性和外源性物质的运输手段,流向每个器官的血流分数决定了与组织持续接触的血浆中溶质的相对质量。因此,当组织由较高比例的心输出量灌注时,不仅药物转运的速率而且其程度都会增加。从年轻人到老年人以及从夜间到白天,衰老和昼夜节律呈现出相似的心输出量分布模式。这两种变化导致老年人和早晨流向肝外肾区域的血流增加,但老年个体的心输出量减少,白天则增加。这种情况使我们能够预测血管外的物质浓度,而血管外物质浓度决定了药物消除的程度和药物作用的强度。因此,关于药物处置和药效学的现有数据可能会从另一个角度得到解释,这对当前的知识提出了挑战。此外,心血管活性药物的给药可能会颠倒药代动力学和药效学反应之间的时间顺序,因为它们可以改变血流分布。

相似文献

1
The influence of cardiovascular physiology on dose/pharmacokinetic and pharmacokinetic/pharmacodynamic relationships.心血管生理学对剂量/药代动力学及药代动力学/药效学关系的影响。
Clin Pharmacokinet. 2006;45(5):433-48. doi: 10.2165/00003088-200645050-00001.
2
The influence of circadian rhythms on the kinetics of drugs in humans.昼夜节律对人体药物动力学的影响。
Expert Opin Drug Metab Toxicol. 2008 Feb;4(2):175-92. doi: 10.1517/17425255.4.2.175.
3
Pharmacokinetic-pharmacodynamic crisis in the elderly.老年人的药代动力学-药效学危机
Am J Ther. 2007 Sep-Oct;14(5):488-98. doi: 10.1097/01.mjt.0000183719.84390.4d.
4
Pharmacokinetic and pharmacodynamic changes in the elderly. Clinical implications.老年人的药代动力学和药效学变化。临床意义。
Clin Pharmacokinet. 1998 Jul;35(1):49-64. doi: 10.2165/00003088-199835010-00004.
5
Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals.开发一种基于生理学的全身药代动力学方法以评估老年人药物的药代动力学
Clin Pharmacokinet. 2016 Dec;55(12):1573-1589. doi: 10.1007/s40262-016-0422-3.
6
Drug dosage in the elderly. Is it rational?老年人的药物剂量。合理吗?
Drugs Aging. 1998 Nov;13(5):357-79. doi: 10.2165/00002512-199813050-00003.
7
Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions.与年龄相关的药代动力学和药效学变化及相关的药物不良反应风险。
Curr Med Chem. 2010;17(6):571-84. doi: 10.2174/092986710790416326.
8
Effects of hypothermia on pharmacokinetics and pharmacodynamics: a systematic review of preclinical and clinical studies.低温对药代动力学和药效学的影响:临床前和临床研究的系统评价。
Clin Pharmacokinet. 2010 May;49(5):277-94. doi: 10.2165/11319360-000000000-00000.
9
Ethnic or racial differences revisited: impact of dosage regimen and dosage form on pharmacokinetics and pharmacodynamics.种族差异再探讨:给药方案和剂型对药代动力学和药效学的影响
Clin Pharmacokinet. 2006;45(10):957-64. doi: 10.2165/00003088-200645100-00001.
10
Simulation of differential drug pharmacokinetics under heat and exercise stress using a physiologically based pharmacokinetic modeling approach.运用基于生理的药代动力学模型方法模拟热和运动应激下的药物差异药代动力学。
Can J Physiol Pharmacol. 2011 May;89(5):365-82. doi: 10.1139/y11-030. Epub 2011 May 31.

引用本文的文献

1
DSM-5 Criteria for Alcohol and Cannabis Use Disorders: Are Older Adults Less Likely to Endorse Certain Criteria?《精神疾病诊断与统计手册》第五版中酒精和大麻使用障碍的标准:老年人认可某些标准的可能性更低吗?
Int J Environ Res Public Health. 2025 May 28;22(6):843. doi: 10.3390/ijerph22060843.
2
Population Pharmacokinetics of Telmisartan in Healthy Subjects and Hypertensive Patients.替米沙坦在健康受试者和高血压患者中的群体药代动力学
Clin Pharmacokinet. 2025 Feb;64(2):285-295. doi: 10.1007/s40262-024-01471-3. Epub 2025 Jan 14.
3
Development of a Population Pharmacokinetic Model for Cyclosporine from Therapeutic Drug Monitoring Data.

本文引用的文献

1
Isosorbide-5-nitrate sustained-release pellets - an example of computer-supported drug development.硝酸异山梨酯控释微丸——计算机支持药物开发的范例。
Pharm Res. 1985 Jan;2(1):30-6. doi: 10.1023/A:1016314005874.
2
The hepatic sinusoid in aging and cirrhosis: effects on hepatic substrate disposition and drug clearance.衰老和肝硬化中的肝血窦:对肝脏底物处置和药物清除的影响。
Clin Pharmacokinet. 2005;44(2):187-200. doi: 10.2165/00003088-200544020-00004.
3
The influence of age and sex on the clearance of cytochrome P450 3A substrates.
从治疗药物监测数据开发环孢素的群体药代动力学模型。
Biomed Res Int. 2021 Apr 8;2021:3108749. doi: 10.1155/2021/3108749. eCollection 2021.
4
Intraperitoneal clearance as a potential biomarker of cisplatin after intraperitoneal perioperative chemotherapy: a population pharmacokinetic study.腹腔廓清作为腹腔围手术期化疗后顺铂的潜在生物标志物:一项群体药代动力学研究。
Br J Cancer. 2012 Jan 31;106(3):460-7. doi: 10.1038/bjc.2011.557. Epub 2011 Dec 15.
5
Influence of efflux transporters on drug metabolism: theoretical approach for bioavailability and clearance prediction.外排转运体对药物代谢的影响:生物利用度和清除率预测的理论方法。
Clin Pharmacokinet. 2011 Feb;50(2):75-80. doi: 10.2165/11539230-000000000-00000.
6
Age differences in biological monitoring of chemical exposure: a tentative description using a toxicokinetic model.化学物暴露生物监测中的年龄差异:基于毒代动力学模型的初步描述
Int Arch Occup Environ Health. 2009 Apr;82(5):669-76. doi: 10.1007/s00420-008-0366-5. Epub 2008 Oct 21.
年龄和性别对细胞色素P450 3A底物清除率的影响。
Clin Pharmacokinet. 2005;44(1):33-60. doi: 10.2165/00003088-200544010-00002.
4
Functional interaction of intestinal CYP3A4 and P-glycoprotein.肠道细胞色素P450 3A4(CYP3A4)与P-糖蛋白的功能相互作用
Fundam Clin Pharmacol. 2004 Dec;18(6):621-6. doi: 10.1111/j.1472-8206.2004.00291.x.
5
Carbamazepine regulates intestinal P-glycoprotein and multidrug resistance protein MRP2 and influences disposition of talinolol in humans.卡马西平可调节肠道P-糖蛋白和多药耐药蛋白MRP2,并影响他林洛尔在人体内的处置。
Clin Pharmacol Ther. 2004 Sep;76(3):192-200. doi: 10.1016/j.clpt.2004.04.011.
6
Aging biology and geriatric clinical pharmacology.衰老生物学与老年临床药理学。
Pharmacol Rev. 2004 Jun;56(2):163-84. doi: 10.1124/pr.56.2.4.
7
Multiplicative dependence of the first order rate constant and its impact on clinical pharmacokinetics and bioequivalence.
Eur J Drug Metab Pharmacokinet. 2004 Jan-Mar;29(1):43-9. doi: 10.1007/BF03190573.
8
Cytochrome P450 3A4 and P-glycoprotein expression in human small intestinal enterocytes and hepatocytes: a comparative analysis in paired tissue specimens.细胞色素P450 3A4和P-糖蛋白在人小肠肠上皮细胞和肝细胞中的表达:配对组织标本的比较分析
Clin Pharmacol Ther. 2004 Mar;75(3):172-83. doi: 10.1016/j.clpt.2003.10.008.
9
The small intestine as a xenobiotic-metabolizing organ.小肠作为一个外源性物质代谢器官。
Drug Metab Dispos. 2003 Dec;31(12):1520-5. doi: 10.1124/dmd.31.12.1520.
10
When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly.当药物治疗不再新鲜:老年人的药代动力学和药效学
Exp Gerontol. 2003 Aug;38(8):843-53. doi: 10.1016/s0531-5565(03)00133-5.